Peganum harmala: Difference between revisions

>David Hedlund
Added more refs for the alkaloid content
>David Hedlund
Linked RIMA
Line 9: Line 9:
*[[Harmine]], 0.44%<ref name=chroma>{{cite journal |vauthors=Pulpati H, Biradar YS, Rajani M |title=High-performance thin-layer chromatography densitometric method for the quantification of harmine, harmaline, vasicine, and vasicinone in Peganum harmala |journal=J AOAC Int |volume=91 |issue=5 |pages=1179–85 |year=2008 |pmid=18980138}}</ref>–1.84%<ref name=partial/>–4.3%<ref name=new1>{{cite journal |vauthors=Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H |title=beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO) |journal=Food Chem. Toxicol. |volume=48 |issue=3 |pages=839–45 |date=March 2010 |pmid=20036304 |doi=10.1016/j.fct.2009.12.019}}</ref>
*[[Harmine]], 0.44%<ref name=chroma>{{cite journal |vauthors=Pulpati H, Biradar YS, Rajani M |title=High-performance thin-layer chromatography densitometric method for the quantification of harmine, harmaline, vasicine, and vasicinone in Peganum harmala |journal=J AOAC Int |volume=91 |issue=5 |pages=1179–85 |year=2008 |pmid=18980138}}</ref>–1.84%<ref name=partial/>–4.3%<ref name=new1>{{cite journal |vauthors=Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H |title=beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO) |journal=Food Chem. Toxicol. |volume=48 |issue=3 |pages=839–45 |date=March 2010 |pmid=20036304 |doi=10.1016/j.fct.2009.12.019}}</ref>
:The coatings of the seeds are said to contain large amounts of harmine.<ref name=cdfa/> Harmine is a nonselective MAO-A and MAO-B inhibitor. The coatings of the seeds are said to contain large amounts of harmine.
:The coatings of the seeds are said to contain large amounts of harmine.<ref name=cdfa/> Harmine is a nonselective MAO-A and MAO-B inhibitor. The coatings of the seeds are said to contain large amounts of harmine.
*[[Harmaline]], 0.25%<ref name=partial/>–0.79%<ref name=chroma/>–5.6%<ref name=new1/> Harmaline is a "reversible inhibitor of MAO-A (RIMA).<ref>{{ cite book | author = Massaro, E. J. | title = Handbook of Neurotoxicology | publisher = Humana Press | location = Totowa, NJ | year = 2002 | isbn = 0-89603-796-7 | url = https://books.google.com/books?id=2c2K-epbCDQC&pg=PA237&lpg=PA237&dq=harmaline+antidepressant | page = 237 }}</ref>
*[[Harmaline]], 0.25%<ref name=partial/>–0.79%<ref name=chroma/>–5.6%<ref name=new1/> Harmaline is a [[RIMA]].<ref>{{ cite book | author = Massaro, E. J. | title = Handbook of Neurotoxicology | publisher = Humana Press | location = Totowa, NJ | year = 2002 | isbn = 0-89603-796-7 | url = https://books.google.com/books?id=2c2K-epbCDQC&pg=PA237&lpg=PA237&dq=harmaline+antidepressant | page = 237 }}</ref>
*[[Harmalol]], 0.6%<ref name=new1/>–3.90%<ref name=partial/>
*[[Harmalol]], 0.6%<ref name=new1/>–3.90%<ref name=partial/>
*[[Tetrahydroharmine]], 0.1%<ref name=new1/>
*[[Tetrahydroharmine]], 0.1%<ref name=new1/>